Chief Medical Officer Isarna Therapeutics GmbH. a clinical stage company focused on RNA therapies for ophthalmic indications. Academic researcher using ML/AI for more than a decade. Professor for Ophthalmology Bern and Chicago with broad clinical interest, a focus on clinical research in retina, uveitis, age-related macular degeneration and cystoid macular edema applying state of the art imaging as optical coherence tomography and functional magnetic resonance tomography. Investigator of many global clinical trials, consultant to the pharmaceutical industry and avid teacher, lecturer, and presenter.